OSLO, Norway, May 22, 2026 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) today announces the launch of Virono®, the first over-the-counter single-dose treatment for recurrent cold sores (herpes labialis) in adults. The launch establishes a new OTC treatment category and represents an...
Hence then, the article about navamedic launches virono the first single dose over the counter cold sore tablet was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Navamedic launches Virono®- the first single-dose over-the-counter cold sore tablet )
Also on site :
- 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
- One of the Most Anticipated Romantasy Books of 2026 Doesn’t Even Have a Title Yet — But Being on the List Isn’t Surprising!
- Fire response spotted on Bermar Park in Gates on Thursday evening